These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 3955779

  • 1. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
    Abbate GF, Alagia I, Giaquinto E, Leonessa V, Caputi M, Guarino C, Micillo E, Catena E, Altucci P.
    Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF, Palombini BC, Dagrosa EE, Mendoza F, Facco EB.
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of netilmicin in the field of internal medicine.
    Abbate GF, Alagia I, Leonessa V, Giaquinto E, Nappi R, Papaleo G, Altucci P.
    Chemioterapia; 1985 Apr; 4(2):176-81. PubMed ID: 3891116
    [Abstract] [Full Text] [Related]

  • 16. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM, Sanz Chinesta S, Jiménez Cruz JF, Flores Corral N, Unda Urzaiz M, Leiva Galvis O, González Romojaro V, Hernández Fernández C, Lledó García E, Rioja Sanz LA, Gonzalvo Ibarra A, Camacho González JE, Ruíz Alvárez-Cienfuegos F, Resel Estévez L, Corral Saleta J, Burgos Rodríguez R, Del Rosal Samaniego JM.
    Actas Urol Esp; 1997 Apr; 21(7):668-74. PubMed ID: 9412209
    [Abstract] [Full Text] [Related]

  • 17. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M, Noschese P, Vinciguerra A, Di Perna F, Califano C, Berra A.
    Minerva Med; 1998 Apr; 89(1-2):15-22. PubMed ID: 9561021
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M, Velluti G.
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV.
    Am J Med; 1984 Oct 19; 77(4C):97-103. PubMed ID: 6093528
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.